THIS IS A DEVELOPMENT VERSION OF PROFILES. PLEASE GO TO THE PRODUCTION ENVIRONMENT FOR UPDATES

Header Logo

Connection

Gary Raskob to Pulmonary Embolism

This is a "connection" page, showing publications Gary Raskob has written about Pulmonary Embolism.
Connection Strength

8.561
  1. Cancer-associated venous thromboembolism: Incidence and features in a racially diverse population. J Thromb Haemost. 2022 10; 20(10):2366-2378.
    View in: PubMed
    Score: 0.745
  2. Extended treatment with edoxaban in cancer patients with venous thromboembolism: A post-hoc analysis of the Hokusai-VTE Cancer study. J Thromb Haemost. 2019 11; 17(11):1866-1874.
    View in: PubMed
    Score: 0.604
  3. New paradigms in venous thromboprophylaxis of medically ill patients. Thromb Haemost. 2017 08 30; 117(9):1662-1670.
    View in: PubMed
    Score: 0.522
  4. Extended duration of anticoagulation with edoxaban in patients with venous thromboembolism: a post-hoc analysis of the Hokusai-VTE study. Lancet Haematol. 2016 May; 3(5):e228-36.
    View in: PubMed
    Score: 0.479
  5. Edoxaban for treatment of venous thromboembolism in patients with cancer. Rationale and design of the Hokusai VTE-cancer study. Thromb Haemost. 2015 Nov 25; 114(6):1268-76.
    View in: PubMed
    Score: 0.459
  6. Importance of subsegmental pulmonary embolism. Blood. 2013 Aug 15; 122(7):1094-5.
    View in: PubMed
    Score: 0.400
  7. Oral direct factor Xa inhibition with edoxaban for thromboprophylaxis after elective total hip replacement. A randomised double-blind dose-response study. Thromb Haemost. 2010 Sep; 104(3):642-9.
    View in: PubMed
    Score: 0.322
  8. Surveillance for deep vein thrombosis and pulmonary embolism: recommendations from a national workshop. Am J Prev Med. 2010 Apr; 38(4 Suppl):S502-9.
    View in: PubMed
    Score: 0.317
  9. Idraparinux versus standard therapy for venous thromboembolic disease. N Engl J Med. 2007 Sep 13; 357(11):1094-104.
    View in: PubMed
    Score: 0.265
  10. Extended prophylaxis of venous thromboembolism with idraparinux. N Engl J Med. 2007 Sep 13; 357(11):1105-12.
    View in: PubMed
    Score: 0.265
  11. Antithrombotic therapy for venous thromboembolic disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004 Sep; 126(3 Suppl):401S-428S.
    View in: PubMed
    Score: 0.215
  12. Clinical utility of D-dimer in patients with suspected pulmonary embolism and nondiagnostic lung scans or negative CT findings. Chest. 2004 Mar; 125(3):851-5.
    View in: PubMed
    Score: 0.208
  13. The economics of venous thromboembolism prophylaxis: a primer for clinicians. Chest. 2003 Dec; 124(6 Suppl):393S-396S.
    View in: PubMed
    Score: 0.204
  14. Helical computed tomography and magnet resonance imaging: diagnosis of pulmonary embolism in symptomatic patients. Curr Opin Hematol. 2003 Sep; 10(5):345-50.
    View in: PubMed
    Score: 0.201
  15. Long-term risk of recurrent venous thromboembolism among patients receiving extended oral anticoagulant therapy for first unprovoked venous thromboembolism: A systematic review and meta-analysis. J Thromb Haemost. 2021 11; 19(11):2801-2813.
    View in: PubMed
    Score: 0.174
  16. Withholding treatment in patients with acute pulmonary embolism who have a high risk of bleeding and negative serial noninvasive leg tests. Am J Med. 2000 Sep; 109(4):301-6.
    View in: PubMed
    Score: 0.163
  17. Effect of Osocimab in Preventing Venous Thromboembolism Among Patients Undergoing Knee Arthroplasty: The FOXTROT Randomized Clinical Trial. JAMA. 2020 01 14; 323(2):130-139.
    View in: PubMed
    Score: 0.156
  18. Diagnosis of pulmonary embolism. Curr Opin Hematol. 1999 Sep; 6(5):280-4.
    View in: PubMed
    Score: 0.152
  19. Heparin and low molecular weight heparin for treatment of acute pulmonary embolism. Curr Opin Pulm Med. 1999 Jul; 5(4):216-21.
    View in: PubMed
    Score: 0.150
  20. Risk Scores for Occult Cancer in Patients with Venous Thromboembolism: A Post Hoc Analysis of the Hokusai-VTE Study. Thromb Haemost. 2018 Jul; 118(7):1270-1278.
    View in: PubMed
    Score: 0.139
  21. RE-COVERY DVT/PE: Rationale and design of a prospective observational study of acute venous thromboembolism with a focus on dabigatran etexilate. Thromb Haemost. 2017 01 26; 117(2):415-421.
    View in: PubMed
    Score: 0.125
  22. Recurrent venous thromboembolism in patients with pulmonary embolism and right ventricular dysfunction: a post-hoc analysis of the Hokusai-VTE study. Lancet Haematol. 2016 Sep; 3(9):e437-45.
    View in: PubMed
    Score: 0.124
  23. Pulmonary embolism among patients with a nearly normal ventilation/perfusion lung scan. Chest. 1996 Aug; 110(2):395-8.
    View in: PubMed
    Score: 0.123
  24. Global Burden of Thrombosis: Epidemiologic Aspects. Circ Res. 2016 Apr 29; 118(9):1340-7.
    View in: PubMed
    Score: 0.121
  25. Global public awareness of venous thromboembolism. J Thromb Haemost. 2015 Aug; 13(8):1365-71.
    View in: PubMed
    Score: 0.114
  26. Anticoagulants and thrombolysis in the treatment of pulmonary embolism. Curr Opin Pulm Med. 1995 Jul; 1(4):291-7.
    View in: PubMed
    Score: 0.114
  27. Risks for major bleeding from thrombolytic therapy in patients with acute pulmonary embolism. Consideration of noninvasive management. Ann Intern Med. 1994 Sep 01; 121(5):313-7.
    View in: PubMed
    Score: 0.108
  28. Oral rivaroxaban for the treatment of symptomatic pulmonary embolism. N Engl J Med. 2012 04 05; 366(14):1287-97.
    View in: PubMed
    Score: 0.091
  29. Enoxaparin followed by once-weekly idrabiotaparinux versus enoxaparin plus warfarin for patients with acute symptomatic pulmonary embolism: a randomised, double-blind, double-dummy, non-inferiority trial. Lancet. 2012 Jan 14; 379(9811):123-9.
    View in: PubMed
    Score: 0.089
  30. Low-probability lung scan findings: a need for change. Ann Intern Med. 1991 Jan 15; 114(2):142-3.
    View in: PubMed
    Score: 0.084
  31. Oral rivaroxaban for symptomatic venous thromboembolism. N Engl J Med. 2010 Dec 23; 363(26):2499-510.
    View in: PubMed
    Score: 0.083
  32. A dose-finding study with TAK-442, an oral factor Xa inhibitor, in patients undergoing elective total knee replacement surgery. Thromb Haemost. 2010 Dec; 104(6):1150-7.
    View in: PubMed
    Score: 0.082
  33. Diagnosis and management of pulmonary thromboembolism. Q J Med. 1990 Aug; 76(280):787-97.
    View in: PubMed
    Score: 0.081
  34. Treatment of venous thromboembolism in patients with cancer: subgroup analysis of the Matisse clinical trials. Thromb Haemost. 2009 Apr; 101(4):762-9.
    View in: PubMed
    Score: 0.074
  35. Anticoagulant therapy for venous thromboembolism. Prog Hemost Thromb. 1989; 9:1-27.
    View in: PubMed
    Score: 0.073
  36. Heparin therapy for venous thrombosis and pulmonary embolism. Blood Rev. 1988 Dec; 2(4):251-8.
    View in: PubMed
    Score: 0.072
  37. Challenges in the diagnosis of acute pulmonary embolism. Am J Med. 2008 Jul; 121(7):565-71.
    View in: PubMed
    Score: 0.070
  38. Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest. 2008 Jun; 133(6 Suppl):454S-545S.
    View in: PubMed
    Score: 0.070
  39. Prevention of central venous catheter-associated thrombosis: a meta-analysis. Am J Med. 2007 Oct; 120(10):901.e1-13.
    View in: PubMed
    Score: 0.067
  40. Frequency of a normal lung scan observed in the urokinase-streptokinase pulmonary embolism trial. Invest Radiol. 1987 Apr; 22(4):357.
    View in: PubMed
    Score: 0.064
  41. Diagnosis of pulmonary embolism. J Am Coll Cardiol. 1986 Dec; 8(6 Suppl B):128B-136B.
    View in: PubMed
    Score: 0.063
  42. Duration of warfarin in pulmonary embolism. Chest. 2006 Jul; 130(1):299; author reply 299-300.
    View in: PubMed
    Score: 0.061
  43. Subcutaneous fondaparinux versus intravenous unfractionated heparin in the initial treatment of pulmonary embolism. N Engl J Med. 2003 Oct 30; 349(18):1695-702.
    View in: PubMed
    Score: 0.051
  44. Pulmonary angiography, ventilation lung scanning, and venography for clinically suspected pulmonary embolism with abnormal perfusion lung scan. Ann Intern Med. 1983 Jun; 98(6):891-9.
    View in: PubMed
    Score: 0.049
  45. Sensitivity and specificity of helical computed tomography in the diagnosis of pulmonary embolism: a systematic review. Ann Intern Med. 2000 Feb 01; 132(3):227-32.
    View in: PubMed
    Score: 0.039
  46. Low-molecular-weight heparin vs heparin in the treatment of patients with pulmonary embolism. American-Canadian Thrombosis Study Group. Arch Intern Med. 2000 Jan 24; 160(2):229-36.
    View in: PubMed
    Score: 0.039
  47. Long-term Anticoagulation With Rivaroxaban for Preventing Recurrent VTE: A Benefit-Risk Analysis of EINSTEIN-Extension. Chest. 2016 Nov; 150(5):1059-1068.
    View in: PubMed
    Score: 0.030
  48. The low-probability lung scan. A need for change in nomenclature. Arch Intern Med. 1995 Sep 25; 155(17):1845-51.
    View in: PubMed
    Score: 0.029
  49. Treatment of venous thromboembolism. Curr Opin Hematol. 1994 Sep; 1(5):329-35.
    View in: PubMed
    Score: 0.027
  50. A noninvasive strategy for the treatment of patients with suspected pulmonary embolism. Arch Intern Med. 1994 Feb 14; 154(3):289-97.
    View in: PubMed
    Score: 0.026
  51. Edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism. N Engl J Med. 2013 Oct 10; 369(15):1406-15.
    View in: PubMed
    Score: 0.025
  52. Venous thromboembolic disease. Curr Opin Cardiol. 1991 Oct; 6(5):750-6.
    View in: PubMed
    Score: 0.022
  53. Clinical validity of a normal perfusion lung scan in patients with suspected pulmonary embolism. Chest. 1990 Jan; 97(1):23-6.
    View in: PubMed
    Score: 0.019
  54. A new noninvasive management strategy for patients with suspected pulmonary embolism. Arch Intern Med. 1989 Nov; 149(11):2549-55.
    View in: PubMed
    Score: 0.019
  55. Pulmonary embolism in outpatients with pleuritic chest pain. Arch Intern Med. 1988 Apr; 148(4):838-44.
    View in: PubMed
    Score: 0.017
  56. Prophylaxis of venous thromboembolism. An overview. Chest. 1986 May; 89(5 Suppl):374S-383S.
    View in: PubMed
    Score: 0.015
  57. The diagnosis of clinically suspected pulmonary embolism. Practical approaches. Chest. 1986 May; 89(5 Suppl):417S-425S.
    View in: PubMed
    Score: 0.015
  58. Prophylaxis of venous thromboembolic disease following hip and knee surgery. J Bone Joint Surg Am. 1986 Jan; 68(1):146-50.
    View in: PubMed
    Score: 0.015
  59. Diagnostic value of ventilation-perfusion lung scanning in patients with suspected pulmonary embolism. Chest. 1985 Dec; 88(6):819-28.
    View in: PubMed
    Score: 0.015
  60. The diagnostic approach to acute venous thromboembolism. Clinical practice guideline. American Thoracic Society. Am J Respir Crit Care Med. 1999 Sep; 160(3):1043-66.
    View in: PubMed
    Score: 0.010
  61. Physician-guided treatment compared with a heparin protocol for deep vein thrombosis. Arch Intern Med. 1994 May 09; 154(9):999-1004.
    View in: PubMed
    Score: 0.007
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

THIS IS A DEVELOPMENT VERSION OF PROFILES. PLEASE GO TO THE PRODUCTION ENVIRONMENT FOR UPDATES